For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Cerulean Pharma Inc.

USPTO Granted Patents = 21

% Expired Patents = 61.9

CIPO Patents = 5

EPO Patents = 3

Forward Citations = 174

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Mark E Davis (15 out of 137 patents)

Jianjun Cheng (15 out of 23 patents)

Kay T Khin (14 out of 15 patents)

4. J Michael Ramstack (6 out of 44 patents)

5. John Podobinski (5 out of 6 patents)

6. David S Dickey (3 out of 5 patents)

7. Thomas Crawford (1 out of 8 patents)

8. Kat T Khin (1 out of 1 patent)

9. Thomas Schluep (1 patent)

10. Jianjun Cheng (22 patents)

11. John M Ryan (23 patents)

12. Scott D Eliasof (2 patents)

21 patents: Sort by Forward Citations

1. 9598503 - Methods and systems for polymer precipitation and generation of particles (2017-03-21),

2. 9550860 - Cyclodextrin-based polymers for therapeutics delivery (2017-01-24),

3. 8809492 - Method for fabricating nanoparticles (2014-08-19),

4. 8680202 - Cyclodextrin-based polymers for therapeutics delivery (2014-03-25),

5. 8618240 - Methods and systems for generating nanoparticles (2013-12-31),

6. 8609081 - Cyclodextrin-based polymers for therapeutics delivery (2013-12-17),

7. 8603454 - Cyclodextrin-based polymers for therapeutics delivery (2013-12-10),

8. 8580244 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),

9. 8580243 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),

10. 8580242 - Cyclodextrin-based polymers for therapeutics delivery (2013-11-12),

11. 8546521 - Method for fabricating nanoparticles (2013-10-01),

12. 8518388 - Cyclodextrin-based polymers for therapeutics delivery (2013-08-27),

13. 8475781 - Cyclodextrin-based polymers for therapeutics delivery (2013-07-02),

14. 8404799 - Methods and systems for generating nanoparticles (2013-03-26),

15. 8404662 - Cyclodextrin-based polymers for therapeutics delivery (2013-03-26),

Cerulean Pharma Inc. is a pharmaceutical company focused on developing innovative nanotechnology-based therapies for the treatment of various cancers. Their proprietary nanoparticle-drug conjugate (NDC) technology enables the precise delivery of potent anti-cancer drugs directly to tumors, enhancing their efficacy while reducing systemic toxicity. With a mission to improve patients' lives, Cerulean Pharma Inc. is committed to advancing the field of oncology through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

21 Patents

#132 in Cambridge, MA

#942 in Massachusetts

#15,662 in US

#29,874 in the World

Cambridge, MA, United States of America

Cerulean Pharma Inc.

Forward Citations = 174

8 inventors:

Mark E Davis (15 out of 137 patents)

Jianjun Cheng (15 out of 23 patents)

Kay T Khin (14 out of 15 patents)

4. J Michael Ramstack (6 out of 44 patents)

5. John Podobinski (5 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…